Blog icon

Work with CSIRO's biomedical researchers

Our biologics capabilities

CSIRO’s biologics facilities play a vital role in the biomedical research industry. Our esteemed scientists and world-class facilities provide companies and other research organisations the opportunity to produce biologics at the scale and quality required for pre-clinical and clinical applications.

Biologics capabilities

Our researchers and unique facilities play a vital role in the biomedical ecosystem. We partner with businesses and produce biologics at the scale and quality required for pre-clinical and clinical applications.

Manufacturing a COVID-19 vaccine

How do we produce a COVID-19 vaccine that is safe, effective and can be mass-produced? We take you into our labs to find out!

Our drug discovery capabilities

Our highly skilled biomedical researchers work with industry to develop, validate and optimise drug discovery. Read more about our capabilities in the infographic below.

MecRx

Melbourne biotech start-up MecRx is working with CSIRO researcher Dr Rohan Volpe to fast track drug discovery.

Developing medicinal cannabis products

Our new licence to manufacture medicinal cannabis products will help drive the development of novel cannabis-based therapeutics in Australia.

CSIRO starts work on medicinal psychedelics

CSIRO, Australia’s national science agency, is aiming to develop new psychedelics to help people with a variety of mental health issues including depression, addiction, end of life anxiety and post-traumatic stress disorder.

This form of B3 can make blood cells more youthful

Our scientists helped find that blood cells can become “more youthful” through exposure to nicotinamide riboside – a form of vitamin B3.

Hitting a nerve: how antidepressants treat nerve pain

Researchers at Australia’s national science agency CSIRO, have shown for the first time how tricyclic antidepressants (TCAs) work against nerve pain, paving the way for further research and new therapies to treat the debilitating condition.

Biomedical Materials Translation Facility

CSIRO's Biomedical Materials Translational Facility (BMTF) helps Medtech companies turn new discoveries into market ready products. It has the capability and equipment needed to develop a biomedical product though prototyping, scale-up, pre-clinical testing and industry evaluation and offers access to ISO 9001, ISO 17025 and GLP.

Medtech to market

CSIRO's Biomedical Materials Translational Facility (BMTF) helps MedTech companies turn new discoveries into biomedical products.

Sidelining delays in diagnosing concussion

We're working on a game-changing new device that could assist first responders to diagnose traumatic brain injuries on the spot.

Golden eye

How we're using gold nano-particles to help treat age-related macular degeneration.

3D printed biomedical implants at Lab22

3D printed biomedical implants at Lab22

We innovate additive manufacturing (3D printing). Our research and development underpins a growing Australian metallic additive manufacturing industry.

How do you mend a broken heart

How do you mend a broken heart

Our latest polymer, LifePolymer™, was recently transplanted into a man in the US in the form of a novel heart valve, to save his life. Talk about Australian technology making a difference to global heart health!

More biomedical research